Arnold HM, Nelson CL, Sarter M, Bruno JP (2003) Sensitization of cortical acetylcholine release by repeated administration of nicotine in rats. Psychopharmacology 165:346–358
Bates T, Pellett O, Stough C, Mangan G (1994) Effects of smoking on simple and choice reaction time. Psychopharmacology 114:365–368
Bettany JH, Levin ED (2001) Ventral hippocampal alpha-7 nicotinic receptor blockade and chronic nicotine effects on memory performance in the radial arm-maze. Pharmacol Biochem Behav 70:464–467
Buccafusco JJ, Jackson WJ, Terry AV Jr, Marsh KC, Decker MW, Arneric SP (1995) Improvement in performance of a delayed matching-to-sample task by monkeys following ABT-418: a novel cholinergic channel activator for memory enhancement. Psychopharmacology 120:256–266
Buccafusco JJ, Letchworth SR, Bencherif M, Lippiello PM (2005) Long lasting cognitive improvement with nicotine receptor agonists: mechanisms of pharmacokinetic–pharmacodynamic discordance. Trends Pharmacol Sci 26:352–360
Calkins ME, Curtis CE, Iacono WG, Grove WM (2004) Antisaccade performance is impaired in medically and psychiatrically healthy biological relatives of schizophrenia patients. Schizophr Res 71:167–178
Clarke PBS, Reuben M (1996) Release of [3H]-noradrenalin from rat hippocampal synaptosomes by nicotine: mediation by different nicotinic receptor subtypes from striatal [3H]-dopamine release. Br J Pharmacol 117:595–606
Corrigall WA, Coen KM, Adamson L (1994) Self-administered nicotine activates the mesolimbic dopamine system through the ventral tegmental area. Brain Res 653:278–284
Dar R, Frenk H (2004) Do smokers self-administer pure nicotine? A review of the evidence. Psychopharmacology 173:18–26
de Leon J, Diaz FJ (2005) A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviors. Schizophr Res 76:135–157
Della Casa V, Hofer I, Feldon J (1999) Latent inhibition in smokers vs nonsmokers: interaction with number or intensity of preexposures. Pharmacol Biochem Behav 62:353–359
Depatie L, O’Driscoll GA, Holahan AV, Atkinson V, Thavundayil JX, Kin NNY, Lal S (2002) Nicotine and behavioural markers of risk for schizophrenia: a double-blind, placebo-controlled, cross-over study. Neuropsychopharmacology 27:1056–1070
Edginton T, Rusted JM (2003) Separate and combined effects of scopolamine and nicotine on retrieval-induced forgetting. Psychopharmacology 170:351–357
Eenshuistra RM, Ridderinkhof KR, van der Molen MW (2004) Age-related changes in antisaccade performance: inhibitory control or working-memory engagement? Brain Cogn 56:177–188
Ernst M, Matochik JA, Heishman SJ, Van Horn JD, Jons PH, Henningfield JE, London ED (2001) Effect of nicotine on brain activation during performance of a working memory task. Proc Natl Acad Sci U S A 98:4728–4733
Ettinger U, Kumari V, Zachariah E, Galea A, Crawford TJ, Corr PJ, Taylor D, Das M, Sharma T (2003a) Effects of procyclidine on eye movements in schizophrenia. Neuropsychopharmacology 28:2199–2208
Ettinger U, Kumari V, Crawford TJ, Davis RE, Sharma T, Corr PJ (2003b) Reliability of smooth pursuit, fixation, and saccadic eye movements. Psychophysiology 40:620–628
Fagerström KO (1978) Measuring degree of physical dependence to tobacco smoking with reference to individualization of treatment. Addict Behav 3:235–241
Fischer B, Weber H (1997) Effects of stimulus conditions on the performance of antisaccades in man. Exp Brain Res 116:191–200
Findlay JM, Walker R (1999) A model of saccade generation based on parallel processing and competitive inhibition. Behav Br Sci 22:661–721
Foulds J, Stapleton J, Swettenham J, Bell N, McSorley K, Russell, MAH (1996) Cognitive performance effects of subcutaneous nicotine in smokers and never-smokers. Psychopharmacology 127:31–38
Griesar WS, Zajdel DP, Oken BS (2002) Nicotine effects on alertness and spatial attention in non-smokers. Nicotine Tob Res 4:185–194
Godijn R, Theeuwes J (2002) Programming of endogenous and exogenous saccades: evidence for a competitive integration model. J Exp Psychol Hum Percept Perform 28:1039–1054
Hallett PE (1978) Primary and secondary saccades to goals defined by instructions. Vis Res 18:1279–1296
Harris JG, Kongs S, Allensworth D, Martin L, Tregellas J, Sullivan B, Zerbe G, Freedman R. (2004) Effects of nicotine on cognitive deficits in schizophrenia. Neuropsychopharmacology 29:1378–1385
Hutton SB, Crawford TJ, Puri BK, Duncan LJ, Chapman M, Kennard C, Barnes TRE, Joyce EM (1998) Smooth pursuit and saccadic abnormalities in first-episode schizophrenia. Psychol Med 28:685–692
Hutton SB, Joyce EM, Barnes TRE, Kennard C (2002) Saccadic distractibility in first-episode schizophrenia. Neuropsychologia 40:1729–1736
Hutton SB, Huddy V, Barnes TR, Robbins TW, Crawford TJ, Kennard C, Joyce EM (2004) The relationship between antisaccades, smooth pursuit, and executive dysfunction in first-episode schizophrenia. Biol Psychiatry 56:553–559
Khan SA, Ford K, Timney B, Everling F (2003) Effects of ethanol on anti-saccade task performance. Exp Brain Res 150:68–74
Kumari V, Postma P (2005) Nicotine use in schizophrenia: the self medication hypothesis. Exp Brain Res 29:1021–1034
Kumari V, Gray JA, Ffytche DH, Mitterschiffthaler MT, Das M, Zachariah E, Vythelingum GN, Williams SCR, Simmons A, Sharma T (2003) Cognitive effects of nicotine in humans: an fMRI study. NeuroImage 19:1002–1013
Larrison AL, Briand KA, Sereno AB (2004) Nicotine improves antisaccade performance without affecting prosaccades. Hum Psychopharmacol 19:409–419
Larrison-Faucher AL, Matorin AA, Sereno AB (2004) Nicotine reduces antisaccade errors in task impaired subjects. Prog Neuro-psychopharmacol Biol Psychiatry 28:505–516
Leigh RJ, Kennard C (2004) Using saccades as a research tool in the clinical neurosciences. Brain 127:460–477
Leonard S, Gault J, Adams C, Breese CR, Rollins Y, Adler LE, Olincy A, Freedman R (1998) Nicotinic receptors, smoking and schizophrenia. Restor Neurol Neurosci 12:195–201
Levin ED, Christopher NC (2002) Persistence of nicotinic agonist RJR 2403 induced working memory improvements in rats. Drug Dev Res 55:97–103
Levin ED, McClernon FJ, Rezvani AH (2006) Nicotinic effects on cognitive function: behavioural characterisation, pharmacological specification and anatomical localisation. Psychopharmacology 184:523–539
Levin ED, Conners CK, Silva D, Hinton SC, Meck WH, March J, Rose JE (1998) Transdermal nicotine effects on attention. Psychopharmacology 140:135–141
Mancuso G, Lejeune M, Ansseau M (2001) Cigarette smoking and attention: processing speed or specific effects? Psychopharmacology 155:372–378
Martin-Ruiz CM, Haroutunian VH, Long P, Young AH, Davis KL, Perry EK, Court JA (2003) Dementia rating and nicotinic receptor expression in the prefrontal cortex in schizophrenia. Biol Psychiatry 54:1222–1233
Massen C (2004) Parallel programming of exogenous and endogenous components in the antisaccade task. Q J Exp Psychol A 57:475–498
Mitchell JP, Macrae CN, Gilchrist ID (2002) Working memory and the suppression of reflexive saccades. J Cogn Neurosci 14:95–103
Munoz DP, Everling S (2004) Look away: the anti-saccade task and the voluntary control of eye movement. Nat Rev Neurosci 5:218–228
Myers CS, Robles O, Kakoyannis AN, Sherr JD, Avila MT, Blaxton TA, Thaker GK (2004) Nicotine improves delayed recognition in schizophrenic patients. Psychopharmacology 174(3):334–340
Nieuwenhuis S, Broerse A, Nielen MMA, de Jong R (2004) A goal activation approach to the study of executive function: An application to antisaccade tasks. Brain Cogn 56:198–214
Nordberg A (2001) Nicotinic receptor abnormalities in Alzheimer’s disease: therapeutic implications. Biol Psychiatry 49:200–210
Paterson D, Nordberg A (2000) Neuronal nicotinic receptors in the human brain. Biol Psychiatry 61:75–111
Perkins KA, Donny E, Caggiula AR (1999) Sex differences in nicotine effects and self-administration: review of human and animal evidence. Nicotine Tob Res 1(4):301–315
Pierrot-Deseilligny C, Müri RM, Ploner CJ, Gaymard B, Demeret S, Rivaud-Pechoux S (2003) Decisional role of the dorsolateral prefrontal cortex in ocular motor behaviour. Brain 126:1460–1473
Poltavski DV, Petros T (2005) Effects of transdermal nicotine on prose memory and attention in smokers and nonsmokers. Physiol Behav 83(5):833–843
Powell J, Dawkins L, Davis RE (2002) Smoking, reward responsiveness and response inhibition: tests of an incentive motivational model. Biol Psychiatry 51:151–163
Reuben M, Clarke PBS (2000) Nicotine evoked [3H]5-hydroxytryptamine release from rat striatal synaptosomes. Neuropharmacology 39:290–299
Reuter B, Kathmann N (2004) Using saccade tasks as a tool to analyze executive dysfunctions in schizophrenia. Acta Psychologica 115:255–269
Roberts RJ, Hager LD, Heron C (1994) Prefrontal cognitive processes: working memory and inhibition in the antisaccade task. Biol Psychiatry 123:374–393
Roos YBWEM, de Jongh FE, Crevits L (1995) The effects of smoking on anti-saccades. Neuro-ophthalmology 15:3–8
Rycroft N, Rusted JM, Hutton SB (2005) Acute effects of nicotine on visual search tasks in young adult smokers. Psychopharmacology 181:160–169
Stuyven E, Van der Goten K, Vandierendonck A, Claeys K, Crevits L (2000) The effect of cognitive load on saccadic eye movements. Acta Psychologica 104:69–85
Unsworth N, Schrock JC, Engle RW (2004) Working memory capacity and the antisaccade task: individual differences in voluntary saccade control. J Exp Psychol Learn Mem Cogn 30:1302–1321
Vidal C, Changeux JP (1993) Nicotinic and muscarinic modulations of excitatory synaptic transmission in the rat prefrontal cortex in vitro. Neuroscience 56:23–32
Warburton DM, Arnall C (1994) Improvements in performance without nicotine withdrawal. Psychopharmacology 115:539–542
West RJ, Jarvis MJ (1986) Effects of nicotine on finger tapping rate in non-smokers. Pharmacol Biochem Behav 25:727–731
Witte EA, Davidson MC, Marrocco RT (1997) Effects of altering brain cholinergic activity on covert orienting of attention: comparison of monkey and human performance. Psychopharmacology 132:324–334